Probiotics and the Management of Inflammatory Bowel Disease
Open Access
- 1 May 2004
- journal article
- review article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 10 (3) , 286-299
- https://doi.org/10.1097/00054725-200405000-00018
Abstract
The demonstration that immune and epithelial cells can discriminate between different microbial species has extended our understanding of the actionsKeywords
This publication has 113 references indexed in Scilit:
- Bovicin HJ50, a novel lantibiotic produced by Streptococcus bovis HJ50Microbiology, 2004
- Bacterial DNA evokes epithelial IL‐8 production by a MAPK‐dependent, NFκB‐independent pathwayThe FASEB Journal, 2003
- VSL3 probiotic mixture induces remission in patients with active ulcerative colitisGastroenterology, 2003
- Interaction of lactic acid bacteria with the gut immune systemEuropean Journal of Clinical Nutrition, 2002
- Probiotics and inflammatory bowel disease: from fads and fantasy to facts and futureBritish Journal of Nutrition, 2002
- Gastrointestinal effects of prebioticsBritish Journal of Nutrition, 2002
- Induction by a Lactic Acid Bacterium of a Population of CD4+T Cells with Low Proliferative Capacity That Produce Transforming Growth Factor β and Interleukin-10Clinical and Diagnostic Laboratory Immunology, 2001
- Maintenance of remission in ulcerative colitis is equally effective with Escherichia coli Nissle 1917 and with standard mesalamineGastroenterology, 2001
- Lactobacillus Bacteremia: Description of the Clinical Course in Adult Patients Without EndocarditisClinical Infectious Diseases, 1996
- Lactobacillus rhamnosus septicemia in patients with prolonged aplasia receiving ceftazidime-vancomycinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991